| Cynthia Ann Ross, MD | |
|
8755 S Harlem Ave, Bridgeview, IL 60455-1905 | |
| (708) 430-2295 | |
| (708) 430-2372 |
| Full Name | Cynthia Ann Ross |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine |
| Experience | 40 Years |
| Location | 8755 S Harlem Ave, Bridgeview, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831389816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 036-081639 (Illinois) | Secondary |
| 208D00000X | General Practice | 036-081639 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Current Care Of Illinois Pc | 6002040276 | 26 |
News Archive
New recommendations co-developed by Dana-Farber Cancer Institute call for a significant expansion of the National Cancer Institute (NCI) and NCI-designated Comprehensive Cancer Centers to understand the causes of inequities in cancer care and a commitment to building sustained community partnerships to reduce them.
Hearing scientist Daniel Polley, Ph.D., an investigator at Massachusetts Eye and Ear Infirmary's Eaton-Peabody Laboratories of Auditory Physiology, has gained new insight into why a relatively short-term hearing deprivation during childhood may lead to persistent hearing deficits, long after hearing is restored to normal.
Illumina, Inc. (NASDAQ: ILMN) today announced that Verinata Health, an Illumina company, received the Clinical Laboratory Permit from the New York State Department of Health for its CLIA-certified, CAP-accredited laboratory.
Cantel Medical Corp., today announced that the company has successfully completed the acquisition of PuriCore International Limited., a wholly-owned subsidiary of PuriCore plc.
› Verified 7 days ago
| Entity Name | American Current Care Of Illinois Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285071241 PECOS PAC ID: 6002040276 Enrollment ID: O20131002000446 |
News Archive
New recommendations co-developed by Dana-Farber Cancer Institute call for a significant expansion of the National Cancer Institute (NCI) and NCI-designated Comprehensive Cancer Centers to understand the causes of inequities in cancer care and a commitment to building sustained community partnerships to reduce them.
Hearing scientist Daniel Polley, Ph.D., an investigator at Massachusetts Eye and Ear Infirmary's Eaton-Peabody Laboratories of Auditory Physiology, has gained new insight into why a relatively short-term hearing deprivation during childhood may lead to persistent hearing deficits, long after hearing is restored to normal.
Illumina, Inc. (NASDAQ: ILMN) today announced that Verinata Health, an Illumina company, received the Clinical Laboratory Permit from the New York State Department of Health for its CLIA-certified, CAP-accredited laboratory.
Cantel Medical Corp., today announced that the company has successfully completed the acquisition of PuriCore International Limited., a wholly-owned subsidiary of PuriCore plc.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia Ann Ross, MD 5080 Spectrum Dr, Ste 1200 W, Addison, TX 75001-4648 Ph: (972) 725-5667 | Cynthia Ann Ross, MD 8755 S Harlem Ave, Bridgeview, IL 60455-1905 Ph: (708) 430-2295 |
News Archive
New recommendations co-developed by Dana-Farber Cancer Institute call for a significant expansion of the National Cancer Institute (NCI) and NCI-designated Comprehensive Cancer Centers to understand the causes of inequities in cancer care and a commitment to building sustained community partnerships to reduce them.
Hearing scientist Daniel Polley, Ph.D., an investigator at Massachusetts Eye and Ear Infirmary's Eaton-Peabody Laboratories of Auditory Physiology, has gained new insight into why a relatively short-term hearing deprivation during childhood may lead to persistent hearing deficits, long after hearing is restored to normal.
Illumina, Inc. (NASDAQ: ILMN) today announced that Verinata Health, an Illumina company, received the Clinical Laboratory Permit from the New York State Department of Health for its CLIA-certified, CAP-accredited laboratory.
Cantel Medical Corp., today announced that the company has successfully completed the acquisition of PuriCore International Limited., a wholly-owned subsidiary of PuriCore plc.
› Verified 7 days ago